These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30503048)

  • 1. High CONUT score predicts poor survival and postoperative HBV reactivation in HBV-related hepatocellular carcinoma patients with low HBV-DNA levels.
    Wang XB; Chen J; Xiang BD; Wu FX; Li LQ
    Eur J Surg Oncol; 2019 May; 45(5):782-787. PubMed ID: 30503048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hepatitis B virus reactivation and surgery-induced immunosuppression in patients with hepatitis B-related hepatocellular carcinoma.
    Xie ZB; Zhu SL; Peng YC; Chen J; Wang XB; Ma L; Bai T; Xiang BD; Li LQ; Zhong JH
    J Surg Oncol; 2015 Nov; 112(6):634-42. PubMed ID: 26421419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
    Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
    Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
    Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.
    Harimoto N; Yoshizumi T; Inokuchi S; Itoh S; Adachi E; Ikeda Y; Uchiyama H; Utsunomiya T; Kajiyama K; Kimura K; Kishihara F; Sugimachi K; Tsujita E; Ninomiya M; Fukuzawa K; Maeda T; Shirabe K; Maehara Y
    Ann Surg Oncol; 2018 Oct; 25(11):3316-3323. PubMed ID: 30051372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib.
    Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q
    Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
    JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
    Harimoto N; Yoshizumi T; Sakata K; Nagatsu A; Motomura T; Itoh S; Harada N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    World J Surg; 2017 Nov; 41(11):2805-2812. PubMed ID: 28653142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Yamamoto T; Ikebe T; Wakasa K; Nishiguchi S; Kinoshita H
    Cancer; 2000 Mar; 88(5):1016-24. PubMed ID: 10699889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma.
    Takagi K; Yagi T; Umeda Y; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Araki H; Fujiwara T
    World J Surg; 2017 Sep; 41(9):2353-2360. PubMed ID: 28389736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.
    Lee JI; Kim JK; Chang HY; Lee JW; Kim JM; Chung HJ; Kim YS; Lee KS
    J Gastroenterol Hepatol; 2014 May; 29(5):1019-27. PubMed ID: 24325315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
    Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
    Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.